These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 198230)

  • 21. Role of the mesostriatal dopamine pathway.
    Strange PG
    Trends Neurosci; 1990 Mar; 13(3):93-5. PubMed ID: 1691877
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of penfluridol of dopamine-sensitive adenylate cyclase in corpus striatum and substantia nigra of rats.
    Seeber U; Kuschinsky K
    Experientia; 1976 Dec; 32(12):1558-9. PubMed ID: 191279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of GABA in the striatal output system: globus pallidus, nucleus entopeduncularis, substantia nigra and nucleus subthalamicus.
    Scheel-Krüger J; Magelund G; Olianas MC
    Adv Biochem Psychopharmacol; 1981; 30():165-86. PubMed ID: 7036675
    [No Abstract]   [Full Text] [Related]  

  • 24. Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.
    Melamed E; Hefti F; Wurtman RJ
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4305-9. PubMed ID: 6254020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurological disturbances, nigrostriate synapses, and iontophoretic dopamine and apomorphine after haloperidol.
    Zarzecki P; Blake DJ; Somjen GG
    Exp Neurol; 1977 Dec; 57(3):956-70. PubMed ID: 200450
    [No Abstract]   [Full Text] [Related]  

  • 26. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
    Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
    Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for NMDA/D2 receptor-receptor interactions in the rat striatum.
    Micheletti G; Lannes B; Warter JM; Zwiller J
    Adv Neurol; 1993; 60():128-32. PubMed ID: 8380517
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term decreases in spontaneous firing of caudate neurons induced by amphetamine in cats.
    Levine MS; Hull CD; Garcia-Rill E; Erinoff L; Buchwald NA; Heller A
    Brain Res; 1980 Jul; 194(1):263-8. PubMed ID: 6247037
    [No Abstract]   [Full Text] [Related]  

  • 29. The influence of striatal stimulation and putative neurotransmitters on identified neurones in the rat substantia nigra.
    Collingridge GL; Davies J
    Brain Res; 1981 May; 212(2):345-59. PubMed ID: 6112050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists.
    You ZB; Herrera-Marschitz M; Nylander I; Goiny M; O'Connor WT; Ungerstedt U; Terenius L
    Neuroscience; 1994 Nov; 63(2):427-34. PubMed ID: 7891856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrastriatal kainic acid: acute effects on electrophysiological and biochemical measures of nigrostriatal dopaminergic activity.
    Braszko JJ; Bannon MJ; Bunney BS; Roth RH
    J Pharmacol Exp Ther; 1981 Feb; 216(2):289-93. PubMed ID: 6257886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine modulation of the effects of gamma-aminobutyric acid on substantia nigra pars reticulata neurons.
    Waszcak BL; Walters JR
    Science; 1983 Apr; 220(4593):218-21. PubMed ID: 6828891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nigrostriatal cell firing action on the dopamine transporter.
    Rodriguez M; Gonzalez S; Morales I; Sabate M; Gonzalez-Hernandez T; Gonzalez-Mora JL
    Eur J Neurosci; 2007 May; 25(9):2755-65. PubMed ID: 17561841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of systemic and intrastriatal injections of haloperidol on striatal dopamine and DOPAC concentrations in rats pretreated by section of nigrostriatal fibres.
    Wuerthele SM; Moore KE
    J Pharm Pharmacol; 1980 Jul; 32(7):507-10. PubMed ID: 6105192
    [No Abstract]   [Full Text] [Related]  

  • 35. Are bilateral nigrostriatal dopaminergic pathways functionally linked in the rat brain? A microdialysis study in conscious rats.
    Santiago M; Cano J; Westerink BH
    Brain Res; 1993 Nov; 628(1-2):187-92. PubMed ID: 8313146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
    Zeevalk GD; Manzino L; Sonsalla PK
    Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct regional differences in dopamine-mediated volume transmission.
    Rice ME
    Prog Brain Res; 2000; 125():277-90. PubMed ID: 11098664
    [No Abstract]   [Full Text] [Related]  

  • 38. Unilateral destruction of dopamine pathways increases ipsilateral striatal serotonin turnover in rats.
    Karstaedt PJ; Kerasidis H; Pincus JH; Meloni R; Graham J; Gale K
    Exp Neurol; 1994 Mar; 126(1):25-30. PubMed ID: 7512513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-inhibition by dopaminergic neurons.
    Groves PM; Wilson CJ; Young SJ; Rebec GV
    Science; 1975 Nov; 190(4214):522-8. PubMed ID: 242074
    [No Abstract]   [Full Text] [Related]  

  • 40. Dopamine released from dendrites in the substantia nigra controls the nigral and striatal release of serotonin.
    Hery F; Soubrie P; Bourgoin S; Motastruc JL; Artaud F; Glowinski J
    Brain Res; 1980 Jul; 193(1):143-51. PubMed ID: 6247027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.